Novartis AG vs Vistra Corp — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Vistra Corp trades at $162.33 (market cap $53.27B). The key difference: Novartis AG is far larger — about 5.4× Vistra Corp's market cap, and Novartis AG pays the higher dividend (3.17%). Which is the better fit depends on your goals.
| NVS | VST | |
|---|---|---|
Market Cap | $290.25B | $53.27B |
Sector | Health | Technology |
52-Week High | $168.62 | $217.92 |
52-Week Low | $113.50 | $134.71 |
Enterprise Value | $330.27B | $75.03B |
Dividend Yield | 3.17% | 0.58% |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →Vistra is a leading integrated retail electricity and power generation company that serves as a critical infrastructure provider for the digital economy. It operates a diversified portfolio of zero-carbon nuclear and renewable assets alongside a massive, flexible natural gas fleet, positioning it as an indispensable partner for energy-intensive AI data centers and industrial electrification.
Read more on VST →